Clinical Evaluation of Imipenem/Cilastatin Sodium as a second Line regimen in Severe Infections Associated with Hematologic Disorders

Shoichiro Tsuda, Hiroyuki Nakai, Tsuyoshi Murakami, Suguru Seryu, Teruyuki Takashima, Shinji Tanaka, Hitoshi Nakagawa, Hikari Nishigaki, Tsukasa Okuda, Kazuhiro Nishida, Shohei Yokota, Masafumi Taniwaki, Shinichi Misawa, Eei Kashima, Hiromi Yashige, Yuko Kuzuyama, Hiroshi Fujii, Tetsuro Nakai, Yasuo Ohkawara, Hitoshi ImanishiShigeo Horiike

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)886-898
Number of pages13
JournalThe Japanese Journal of Antibiotics
Volume44
Issue number8
DOIs
StatePublished - Dec 1991

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Tsuda, S., Nakai, H., Murakami, T., Seryu, S., Takashima, T., Tanaka, S., Nakagawa, H., Nishigaki, H., Okuda, T., Nishida, K., Yokota, S., Taniwaki, M., Misawa, S., Kashima, E., Yashige, H., Kuzuyama, Y., Fujii, H., Nakai, T., Ohkawara, Y., ... Horiike, S. (1991). Clinical Evaluation of Imipenem/Cilastatin Sodium as a second Line regimen in Severe Infections Associated with Hematologic Disorders. The Japanese Journal of Antibiotics, 44(8), 886-898. https://doi.org/10.11553/antibiotics1968b.44.886